Understanding COVID-19 Vaccine Immunity in Tissue and Blood
NCT05682625 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2024-09-19
Summary
The purpose of this study is to understand the effects of COVID-19 vaccines on the immune system and how the COVID-19 vaccines provide protection and induce long term memory. Adults who are receiving a COVID-19 vaccine will be invited to participate in this study.
Conditions
- COVID-19 (Coronavirus Disease 2019)
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH - lead OTHER
Principal Investigators
-
R. Sharon Chinthrajah, MD · Stanford University, Sean N. Parker Center for Allergy and Asthma Research
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2029-09-30
- Completion
- 2029-09-30
Countries
- United States
Study Locations
More Related Trials
-
VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
NCT01132859 ·Status: RECRUITING
-
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
NCT05164016 ·Status: COMPLETED
-
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932 ·Status: RECRUITING
-
Immune Response to COVID-19 Vaccine in Immunotherapy (IO) and Non-IO Treated Cancer Patients
NCT05062525 ·Status: COMPLETED
-
T Cells Response to SARS COV 2 Peptides
NCT04573348 ·Status: UNKNOWN
-
CD8 Reactivity to Microorganisms in Blood and Breast Milk
NCT03084614 ·Status: TERMINATED
-
Transcriptomics Signature of Anti Vaccinia Memory B Cells
NCT02556489 ·Status: UNKNOWN
-
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
NCT00001158 ·Status: COMPLETED
-
Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment
NCT04779996 ·Status: UNKNOWN
-
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
NCT04743388 ·Status: UNKNOWN
-
Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer
NCT05228275 ·Status: ACTIVE_NOT_RECRUITING
-
Immunity to Infection in Healthy Participants and Participants With Cancer
NCT05787964 ·Status: ACTIVE_NOT_RECRUITING
-
Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors
NCT03114566 ·Status: TERMINATED
-
Prospective Study of White Blood Cells
NCT04838171 ·Status: RECRUITING
-
Immunosuppression and COVID-19 Boosters
NCT05415267 ·Status: RECRUITING ·Phase: PHASE3
-
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
NCT03207854 ·Status: RECRUITING
-
An Open Label Study of IgG Fc Glycan Composition in Human Immunity
NCT01967238 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
NCT01882582 ·Status: COMPLETED
-
Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals
NCT04858607 ·Status: COMPLETED
-
COVID-19 Antibody Levels After Vaccines
NCT04944134 ·Status: COMPLETED
-
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
NCT00346619 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Cell Response to Stimuli
NCT00397280 ·Status: RECRUITING
-
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
NCT04836793 ·Status: UNKNOWN
-
ImmuneRACE - Immune Response Action to COVID-19 Events
NCT04494893 ·Status: COMPLETED
-
Sargramostim for Myeloid Dendritic Cell Deficiency
NCT03063242 ·Status: TERMINATED ·Phase: PHASE2